29 mar 2021
Treatment of Grover Disease With Dupilumab
Treatment of Grover Disease With Dupilumab
23 mar 2021
Is there an association between long-term antibiotics
Antimicrobial resistance (AMR) is a global health emergency.
23 mar 2021
Are biologics combined with methotrexate better
To investigate if the combination of biologics with methotrexate (MTX)
23 mar 2021
Biomarkers in atopic dermatitis
Atopic dermatitis (AD) is a common yet complex skin disease, posing a therapeutic challenge with increasingly recognized different phenotypes among variable patient populations.
16 mar 2021
Note informative per i pazienti - vaccini anti SARS-COV-2 in Italia
Vaccini anti SARS-CoV-2 in uso in Italia
16 mar 2021
Vitiligo
Vitiligo is an autoimmune skin condition characterized by depigmented macules and patches, and has a huge psychosocial impact on patients.
16 mar 2021
Oral minoxidil treatment for hair loss
Although topical minoxidil is an effective treatment option for hair loss
16 mar 2021
The use of hydroxychloroquine
Erosive lichen planus affecting the vulva and vagina (ELPV)
15 mar 2021
Polizza RC professionale e Covid-19
La polizza copre l’attività di somministratore di vaccini
10 mar 2021
Impact of delay in follow-up due to COVID-19
The COVID-19 pandemic required the setting of a national lockdown in Italy from March 9, 2020, until May 18, 2020
10 mar 2021
Lichen simplex chronicus of the scalp
Scalp lichen simplex chronicus (LSC) is rare and can be a challenging and frustrating condition for both patient and physician.
10 mar 2021
Updated international expert recommendations
The SARS-CoV-2 pandemic has worsened since publication
10 mar 2021
Dermoscopy of Syringotropic and Folliculotropic
Dermoscopy of Syringotropic and Folliculotropic Mycosis Fungoides
04 mar 2021
Studio n. 7.ADR-VAX-COVID
Studio osservazionale nazionale prospettico atto a valutare la prevalenza, le caratteristiche cliniche ed in fattori di rischio per l’insorgenza di reazioni avverse cutaneo-mucose a vaccini anti SARS-CoV-2
04 mar 2021
Studio n. 6. ADOAD-DUPI-COV
Studio osservazionale nazionale sull'impiego del biologico anti-IL4 e IL-13 dupilumab nel trattamento della dermatite atopica moderata-grave negli adolescenti (età da ≥ 12 anni a <18 anni): valutazione dell'efficacia e della sicurezza ai tempi dell'infezione SARS-COV2
04 mar 2021
GIDV - Anno 2020 - Volume 155 - Numero 6
Dicembre 2020 - Giornale Italiano di Dermatologia e Venereologia
04 mar 2021
A 48-week update
A 48-week update of a multicentre real-life experience of dupilumab in adult patients
04 mar 2021
The clinical spectrum of COVID-19
COVID-19 is associated with a wide range of skin manifestations.
04 mar 2021
Real-Time Confocal Imaging
Hidradenitis suppurativa (HS) is a chronic, recurrent, inflammatory skin disease involving the follicular unit.
24 feb 2021
Vademecum SIDeMaST per i pazienti sottoposti a vaccini anti SARS-CoV-2
Vademecum SIDeMaST sulla definizione di rischio e relative raccomandazioni di azione per i pazienti che dovranno essere sottoposti a vaccini anti SARS-CoV-2